Brind.

Beta Bionics received FDA clearance for its iLet Bionic Pancreas device on August 21, 2025.

3 reports, 2 independent Updated Sep 19
Gone quiet
Reports
3
Developments
3
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Beta Bionics received FDA clearance for its iLet Bionic Pancreas device on August 21, 2025.

Who's involved

What this event is mainly about
FDABETA BIONICS, INC.

How it developed

Newest first. Tap a step to see who reported it.
  1. Beta Bionics received a Form 483 from the FDA concerning its iLet product.1 source
  2. Collaboration integrates dual sensor with iLet system.Sub-event
  3. Beta Bionics received FDA clearance for its iLet Bionic Pancreas device.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • pr-inside.com
  • GlobeNewswireBeta Bionics Announces Participation at Upcoming Investor Conferences IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of ad
  • Unknown outlet